Immunopharmacological aspects of the cytokine system
Cytokines represent a unique family of endogenous polypeptide mediators of intercellular interaction. From an immunopharmacological point of view cytokines can be marked out as a new, separate immunoregulatory molecule system and have some common biochemical properties and pleiotropic type of biolog...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2019-05-01
|
Series: | Bûlleten' Sibirskoj Mediciny |
Subjects: | |
Online Access: | https://bulletin.tomsk.ru/jour/article/view/2173 |
id |
doaj-5ba50cdd5a65436e936818c233bc7530 |
---|---|
record_format |
Article |
spelling |
doaj-5ba50cdd5a65436e936818c233bc75302021-07-29T08:38:06ZengSiberian State Medical University (Tomsk)Bûlleten' Sibirskoj Mediciny1682-03631819-36842019-05-01181849510.20538/1682-0363-2019-1-84-951483Immunopharmacological aspects of the cytokine systemA. S. Simbirtsev0Immunopharmacological aspects of the cytokine systemCytokines represent a unique family of endogenous polypeptide mediators of intercellular interaction. From an immunopharmacological point of view cytokines can be marked out as a new, separate immunoregulatory molecule system and have some common biochemical properties and pleiotropic type of biological activity. In the cytokine regulatory system both reduction and elevation of cytokine levels can cause pathology. Several endogenous systems exist to control cytokine elevation and prevent tissue pathology. When synthesized simultaneously, cytokines form a cytokine chain. Deletion of any unit of this chain leads to the break in the formation of immunopathology. Cytokines as therapeutic preparations have evident advantages but also some limitations such as pharmacokinetics with short circulation period, adverse effects due to pleiotropic mode of action, and injectable drug forms. Rational design for clinical cytokine application could be linked with the development of prolonged and local drug forms or personalized cytokine therapy.https://bulletin.tomsk.ru/jour/article/view/2173cytokine systemimmunopharmacology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. S. Simbirtsev |
spellingShingle |
A. S. Simbirtsev Immunopharmacological aspects of the cytokine system Bûlleten' Sibirskoj Mediciny cytokine system immunopharmacology |
author_facet |
A. S. Simbirtsev |
author_sort |
A. S. Simbirtsev |
title |
Immunopharmacological aspects of the cytokine system |
title_short |
Immunopharmacological aspects of the cytokine system |
title_full |
Immunopharmacological aspects of the cytokine system |
title_fullStr |
Immunopharmacological aspects of the cytokine system |
title_full_unstemmed |
Immunopharmacological aspects of the cytokine system |
title_sort |
immunopharmacological aspects of the cytokine system |
publisher |
Siberian State Medical University (Tomsk) |
series |
Bûlleten' Sibirskoj Mediciny |
issn |
1682-0363 1819-3684 |
publishDate |
2019-05-01 |
description |
Cytokines represent a unique family of endogenous polypeptide mediators of intercellular interaction. From an immunopharmacological point of view cytokines can be marked out as a new, separate immunoregulatory molecule system and have some common biochemical properties and pleiotropic type of biological activity. In the cytokine regulatory system both reduction and elevation of cytokine levels can cause pathology. Several endogenous systems exist to control cytokine elevation and prevent tissue pathology. When synthesized simultaneously, cytokines form a cytokine chain. Deletion of any unit of this chain leads to the break in the formation of immunopathology. Cytokines as therapeutic preparations have evident advantages but also some limitations such as pharmacokinetics with short circulation period, adverse effects due to pleiotropic mode of action, and injectable drug forms. Rational design for clinical cytokine application could be linked with the development of prolonged and local drug forms or personalized cytokine therapy. |
topic |
cytokine system immunopharmacology |
url |
https://bulletin.tomsk.ru/jour/article/view/2173 |
work_keys_str_mv |
AT assimbirtsev immunopharmacologicalaspectsofthecytokinesystem |
_version_ |
1721253248304676864 |